News
USA Clinical Trials
June 1, 2025
No Comments
We recently updated our projected timeline for US based clinical trials for Investigational Product Immune12 which will be done in association with our ongoing FDA reviews and approvals.
Glioblastoma Drug Development Summit Boston 2025
June 1, 2025
No Comments
PMB researchers shared results of pre-clinical evaluations of Immune-12 with industry and academia at the GBM Drug Development Summit. Immune-12 shows promising antitumor effects in various cancers, with ongoing pre-clinical evaluations at the University of North Carolina.
The study aims to evaluate the antitumor potency, characterize the makeup, and determine the mechanisms of Immune-12.